Literature DB >> 18789685

Kinase array design, back to front: biaryl amides.

Ian Baldwin1, Paul Bamborough, Claudine G Haslam, Suchete S Hunjan, Tim Longstaff, Christopher J Mooney, Shila Patel, Jo Quinn, Don O Somers.   

Abstract

New kinase inhibitors can be found by synthesis of targeted arrays of compounds designed using system-based knowledge as well as through screening focused or diverse compounds. Most array strategies aim to add functionality to a fragment that binds in the purine subpocket of the ATP-site. Here, an alternative pharmacophore-guided array approach is described which set out to discover novel purine subpocket-binding groups. Results are shown for p38alpha and cFMS kinase, for which multiple distinct series with nanomolar potency were discovered. Some of the compounds showed potency in cell-based assays and good pharmacokinetic properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789685     DOI: 10.1016/j.bmcl.2008.08.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

Authors:  Natalie B Vinh; Jamie S Simpson; Peter J Scammells; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2012-04-20       Impact factor: 3.686

2.  Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.

Authors:  Christopher W Murray; Valerio Berdini; Ildiko M Buck; Maria E Carr; Anne Cleasby; Joseph E Coyle; Jayne E Curry; James E H Day; Phillip J Day; Keisha Hearn; Aman Iqbal; Lydia Y W Lee; Vanessa Martins; Paul N Mortenson; Joanne M Munck; Lee W Page; Sahil Patel; Susan Roomans; Kirsten Smith; Emiliano Tamanini; Gordon Saxty
Journal:  ACS Med Chem Lett       Date:  2015-06-04       Impact factor: 4.345

3.  A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.

Authors:  Hidehisa Iwata; Hideyuki Oki; Kengo Okada; Terufumi Takagi; Michiko Tawada; Yasushi Miyazaki; Shinichi Imamura; Akira Hori; J David Lawson; Mark S Hixon; Hiroyuki Kimura; Hiroshi Miki
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

4.  Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach.

Authors:  Kingkan Sanphanya; Suvara K Wattanapitayakul; Suwadee Phowichit; Valery V Fokin; Opa Vajragupta
Journal:  Bioorg Med Chem Lett       Date:  2013-03-20       Impact factor: 2.823

5.  DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.

Authors:  Peter Man-Un Ung; Avner Schlessinger
Journal:  ACS Chem Biol       Date:  2014-12-09       Impact factor: 5.100

6.  Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations.

Authors:  Shailima Rampogu; Ayoung Baek; Amir Zeb; Keun Woo Lee
Journal:  BMC Cancer       Date:  2018-03-07       Impact factor: 4.430

7.  Discovery of Small Molecules that Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies.

Authors:  Shailima Rampogu; Ayoung Baek; Chanin Park; Shraddha Parate; Saravanan Parameswaran; Yohan Park; Baji Shaik; Ju Hyun Kim; Seok Ju Park; Keun Woo Lee
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

8.  De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.

Authors:  Robert Urich; Grant Wishart; Michael Kiczun; André Richters; Naomi Tidten-Luksch; Daniel Rauh; Brad Sherborne; Paul G Wyatt; Ruth Brenk
Journal:  ACS Chem Biol       Date:  2013-03-27       Impact factor: 5.100

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.